Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/12/2020
HitGen to Acquire Vernalis for $25M in Cash
10/12/2020
China Sharpens Focus on Healthcare Cost Containment amid a Basket of M...
10/11/2020
CStone Announces Completion of $200 million Share Sale to Pfizer
10/11/2020
Antengene Announces Collaboration with WuXi Biologics to Advance the D...
10/11/2020
2020 Fall/Winter Promotion - Pharma China publications
10/10/2020
Innovent and Lilly Announce the NMPA Approval of HALPRYZA® (Rituximab...
10/10/2020
CDE Seeks Comments on Draft ICH Guideline E14-S7B
10/10/2020
NHSA and MOF Issues Joint Notice to Advance the Trial for Inter-Provin...
10/9/2020
Everest Medicines Launches IPO in Hong Kong
10/9/2020
Corvus Pharma to Enter China through JV with Local Investor Group
10/9/2020
Fosun's Hengenix to Initiate Trial of COVID-19 Antibody Drug in the U....
10/9/2020
China Reduces VAT on A New Batch of Anticancer Drugs
10/9/2020
Recent Executive Moves
10/9/2020
NMPA Issues the Guide to Pharmaceutical Contract Manufacture Quality A...
10/9/2020
WiCON Publishes the China Pharmaceutical Guide 2020 (15th Edition)
10/8/2020
Boehringer Ingelheim Pledges Continued Direct Investments in China
10/8/2020
Genor Completes $371 Million Hong Kong IPO; Market Cap Reaches $1.8B
10/8/2020
Lilly and Innovent Close the Expanded Global Collaboration on TYVYT (S...
10/8/2020
WiCON|Pharma China Is Now on Twitter, Facebook and LinkedIn
10/8/2020
Simultaneous Development of Zanubrutinib in the U.S. and China Demonst...
10/7/2020
OBI Pharma Taps Delos to Develop Its Drugs in China
10/7/2020
BioShin Raises $60M in Series A Funding to Advance Neuroscience Pipeli...
10/7/2020
Harbour BioMed Announces Two NMPA IND Clearances for Phase 1 & Combo ...
10/7/2020
Hinova Pharma Completes Series C Funding Round Worth $147M
10/7/2020
India Probes Alleged API Dumping by Chinese Companies
10/7/2020
BioAtla and BeiGene Revise Global Deal for Novel Conditionally Active ...
10/4/2020
Q&A with Pfizer CentreOne on Contract Manufacturing for China
10/2/2020
NHC Solicits Public Comments on PRC Law on Prevention and Treatment of...
9/30/2020
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical S...
9/30/2020
CDE Solicits Comments on the Technical Guidelines for Pharmaceutical S...
Page:
162
/
719
Total number of articles:
21562
:
[First]
[<<]
[160]
[161]
[162]
[163]
[164]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit